Clinical TrialsZanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Zanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Read Post »
Clinical TrialsTaltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Taltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Read Post »
New Drug ApprovalFirst New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval First New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval Read Post »
Health TidingsLilly to Acquire Merida Biosciences for Up to $2.875 Billion to Advance Pre... Lilly to Acquire Merida Biosciences for Up to $2.875 Billion to Advance Pre... Read Post »
Clinical TrialsRepatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Repatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Read Post »
Health TidingsKaryopharm Files sNDA for Selinexor Combination in Myelofibrosis Karyopharm Files sNDA for Selinexor Combination in Myelofibrosis Read Post »
Health TidingsSaroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Saroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Read Post »
Health TidingsTNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss TNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss Read Post »
Health TidingsAZD5462 Shows Early Effects in Phase IIb Heart Failure Trial AZD5462 Shows Early Effects in Phase IIb Heart Failure Trial Read Post »
Clinical TrialsNew Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups New Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups Read Post »
Clinical TrialsKey QRX003 Interim Results Reveal Improvement in Netherton Syndrome Key QRX003 Interim Results Reveal Improvement in Netherton Syndrome Read Post »
Clinical TrialsCamzyos Shows Strong Five-Year Results in Patients With oHCM Camzyos Shows Strong Five-Year Results in Patients With oHCM Read Post »
New Drug ApprovalNew Hope for Polycythemia Vera: FDA Approves MIMRYLO New Hope for Polycythemia Vera: FDA Approves MIMRYLO Read Post »
Health TidingsFDA Expands Stelara to Pediatric Ulcerative Colitis FDA Expands Stelara to Pediatric Ulcerative Colitis Read Post »
Clinical TrialsCRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year CRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year Read Post »
Health TidingsFDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... FDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... Read Post »
Health TidingsBioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues BioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues Read Post »
Health TidingsMBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... MBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... Read Post »
Clinical TrialsAficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Read Post »
Clinical TrialsMiv-cel CAR T Therapy Shows Promise in Refractory RA Miv-cel CAR T Therapy Shows Promise in Refractory RA Read Post »
New Drug ApprovalFDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... FDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... Read Post »
Health Tidings Mergers & AcquisitionsDualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... DualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... Read Post »
Health TidingsPfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Pfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Read Post »
Health TidingsSOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma SOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma Read Post »
New Drug ApprovalFDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... FDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... Read Post »
Clinical TrialsPaxalisib Shows Early Clinical Activity in Advanced TNBC Paxalisib Shows Early Clinical Activity in Advanced TNBC Read Post »
New Drug ApprovalModerna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Moderna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Read Post »
New Drug ApprovalHUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... HUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... Read Post »
Clinical TrialsiECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... iECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... Read Post »
Clinical TrialsCorvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Corvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Read Post »
Health TidingsNatera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Natera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Read Post »
Health TidingsGenerate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Generate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Read Post »
Clinical TrialsPositive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Positive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Read Post »
Health TidingsAbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease AbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease Read Post »
ResearchStopping Statins After 75: What a New Randomized Trial Found Stopping Statins After 75: What a New Randomized Trial Found Read Post »
Health TidingsGV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... GV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... Read Post »
Health TidingsZepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Zepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Read Post »
Health TidingsBausch Advances Dual-Action Dry Eye Drop to Phase 3 Despite Missing Phase 2... Bausch Advances Dual-Action Dry Eye Drop to Phase 3 Despite Missing Phase 2... Read Post »
Clinical TrialsSpyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Spyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Read Post »
Clinical TrialsCan a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Can a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Read Post »
New Drug ApprovalRevolution Medicines’ RASONQUE (Daraxonrasib) Becomes First Approved RAS(... Revolution Medicines’ RASONQUE (Daraxonrasib) Becomes First Approved RAS(... Read Post »
Clinical TrialsTRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... TRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... Read Post »
Clinical TrialsCelcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Celcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Read Post »
Health TidingsMahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-... Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-... Read Post »
Clinical TrialsNeurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Neurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Read Post »
Health TidingsAirway Therapeutics Raises $50 Million to Advance Zelpultide Alfa in Bronch... Airway Therapeutics Raises $50 Million to Advance Zelpultide Alfa in Bronch... Read Post »
Health TidingsAbbott’s Libre Duo 10 Day Receives FDA Authorization for Continuous G... Abbott’s Libre Duo 10 Day Receives FDA Authorization for Continuous G... Read Post »
Health TidingsPeptron Advances PT403 Into Phase 1 Development as Once-Monthly Semaglutide... Peptron Advances PT403 Into Phase 1 Development as Once-Monthly Semaglutide... Read Post »
Clinical TrialsAriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... AriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... Read Post »
Health TidingsCaliway Advances CBL-514 With FDA-Cleared Tirzepatide Trial and Phase 3 Enr... Caliway Advances CBL-514 With FDA-Cleared Tirzepatide Trial and Phase 3 Enr... Read Post »
